From A Very Different Angle: Bristol-Myers Squibb Company (BMY), United States Steel Corporation (X)

You should consider shares of Bristol-Myers Squibb Company (NYSE:BMY) and United States Steel Corporation (NYSE:X) if you are looking for a great stocks to invest in. Starting with the BMY shares, which traded at $57.75 at the close of the recent session, gaining 0.59%. On Tuesday, the company’s shares shed $0.34 from its value which represented in intraday trading. The stock is now 8.02% higher in year-to-date (YTD) trading. BMY’s intraday high was $57.81 while its lowest price touched $56.68. The stock’s 52-week high price is $59.17, which means the current price is at -2.41%. In terms of trading activity, the daily trading volume rose to 16228203 against 200-day average trading volume of 15,649,791 shares.

What are analyst forecasts for Bristol-Myers Squibb Company (NYSE:BMY)?

At a consensus rating of 4.23, BMY is trending as a streaking Moderate Buy, as it has been the case a month ago when 11 analysts called it a Moderate Buy. Two months ago, 12 analysts recommended, on average, that BMY stock is a Moderate Buy. The Healthcare company’s shares’ overall bullish trend saw it close higher on Tuesday compared to its opening price of $57.00 on the day.

Forecasts for Bristol-Myers Squibb Company (NYSE:BMY) give the stock a fair value for the growth of 9.77% from its last price. The 12-month price forecast for the stock by analysts puts the stock’s mean price target at $64.00, which means the price per share could rise by nearly $6.25. The price range target is between a low of $53.00 and a high of $75.00. The stock would need to gain by about $23.0 to hit the estimated high or 0.74% from its 12-month low.

The consensus among 13 analysts is that it is a good time for one to Overweight in the Bristol-Myers Squibb Company. 6 analysts rate BMY as a Buy, with 0 of 13 analysts rate it as a Sell. 2 have valued the stock as Overweight and 5 have recommended that investors Hold.

Bristol-Myers Squibb Company (NYSE:BMY) Upgrades and Downgrades

In terms of rating changes, Morgan Stanley on November 22, 2019, Resumed Bristol-Myers Squibb Company (BMY) at Equal-Weight. They believe the stock could reach $60 in the near term. Analysts at BofA/Merrill have assigned a Buy rating for the stock in their research note on October 17, 2019 with an estimated price target of $60. Moreover, Atlantic Equities analysts issued a rating of Overweight for the stock on August 14, 2019, giving it a price target of $63 for the next 12 months. On May 28, 2019, the stock earned a Buy rating due to an analyst call from Goldman, while analysts from Argus on May 20, 2019 suggested that the stock is Hold.

United States Steel Corporation (NYSE:X) adds -$0.53 on Tuesday

The X stock has tanked -27.96% year-to-date and is currently trading at $13.14, which is -46.89% below its 52-week high. The company shares lost -3.88% on the day and have risen nearly 32.33% off a low hit. At current levels, United States Steel Corporation has a valuation of about $13.80B. As of 12/03/19, this stock has fallen -4.71% during the week and closed at $13.67 in the previous session. However, recent United States Steel Corporation stock performance shows that X shares are -0.53% down over the last month, and 16.70% up for the last three months.

Earnings per share (EPS) estimates for the current quarter are $1.84, with the trailing 12-month share earnings at $3.54. The ratio is expected to be down by -99.10% for the current year 2019 and -1,360.00% for next year. Over the next 5-year period, earnings per share will be -32.26%. But will the X stock surprise in the current quarter results, where the -$0.21 actual EPS reported on 9/29/2019 surprised by 27.60% or was higher by $0.08 from the estimated -$0.29.

Sales Growth to decline -5.50% for the year

How well will United States Steel Corporation perform as a business over the current quarter, year and next 5-year period? Compared to the year-ago quarter, analysts forecast the company to bring in between $2.63B and $3.03B in current quarter sales. The consensus estimated for the current quarter is $2.85B from sales. Forecasts for this fiscal year are between $12.62B and $13.15B and the consensus estimate for sales is at $12.94B. X has its next quarter sales estimates at between $2.72B and $3.2B, with the quarter-over-quarter growth estimates at -12.90% and the annual growth forecast for the year at -5.50%.

Who owns shares in United States Steel Corporation (X)?

Let’s briefly focus on the share ownership of the United States Steel Corporation (NYSE:X) stock, where we find that 70.57% of shares are held by institutions. Vanguard Group, Inc. (The) tops the list of institutional owners as it is holding 15.58 million shares or 9.17% of shares outstanding. Blackrock Inc. and Dimensional Fund Advisors LP held 15.12 million and 9.88 million representing 8.89% and 5.81% respectively at the close of the last trading session. As of Sep 29, 2019, Renaissance Technologies, LLC accounted for 7.09 million shares at over 81.84 million. This represented 4.17% of shares outstanding. State Street Corporation held 5.79 million shares at over 66.93 million representing 3.41% of shares outstanding.

X Insider Activity

On 2/22/2019, by the name Ulbrich Greenstein Sara sold 8659.0 shares worth $209200.0 at the price of $24.16 per share. Filings also show that Bradley Kevin P bought a total of 10000.0 shares on 12/13/2018 valued at $203200.0. Since the last insider activity, the company’s share price has dropped -32.36%.